Proton beam therapy for pediatric ependymoma

Pediatrics International

Volumn 57, Issue 4, 2015, Pages 567-571

  Mizumoto, Masashi ^a   Oshiro, Yoshiko ^a,b   Takizawa, Daichi ^a   Fukushima, Takashi ^a   Fukushima, Hiroko ^a   Yamamoto, Tetsuya ^a   Muroi, Ai ^a   Okumura, Toshiyuki ^a   Tsuboi, Koji ^a   Sakurai, Hideyuki ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b TSUKUBA MEDICAL CENTER HOSPITAL   (Japan)

Author keywords

brain; ependymoma; pediatric; proton beam therapy; radiotherapy

Indexed keywords

ACUTE TOXICITY; ALOPECIA; ARTICLE; BRAIN SURGERY; CANCER SURGERY; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DAILY LIFE ACTIVITY; DISEASE SEVERITY; EPENDYMOMA; FEMALE; HUMAN; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTON THERAPY; RADIATION DERMATITIS; RADIATION DOSE; SEIZURE; SIMULATION; TREATMENT PLANNING; TUMOR CLASSIFICATION; TUMOR RECURRENCE; WORLD HEALTH ORGANIZATION; FOLLOW UP; PROCEDURES; RETROSPECTIVE STUDY; TIME FACTOR; TREATMENT OUTCOME; X-RAY COMPUTED TOMOGRAPHY;

CHILD; CHILD, PRESCHOOL; EPENDYMOMA; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PROTON THERAPY; RETROSPECTIVE STUDIES; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84940593817     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/ped.12624     Document Type: Article

References (24)

1. CBTRUS. Statistical report: Primary brain tumors in the United States, 2004-2006. Central Brain Tumor Registry of the United States, Hinsdale, IL, 2010.
2. Merchant TE, Mulhern RK, Krasin MJ, et-‰al. Preliminary results from a phase II trial of conformal radiation therapy and evaluation of radiation-related CNS effects for pediatric patients with localized ependymoma. J. Clin. Oncol. 2004; 22: 3156-3162.
3. Landau E, Boop FA, Conklin HM, Wu S, Xiong X, Merchant TE,. Supratentorial ependymoma: Disease control, complications, and functional outcomes after irradiation. Int. J. Radiat. Oncol. Biol. Phys. 2013; 85: e193-199.
4. Conter C, Carrie C, Bernier V, et-‰al. Intracranial ependymomas in children: Society of Pediatric Oncology experience with postoperative hyperfractionated local radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 2009; 74: 1536-1542.
5. Merchant TE, Li C, Xiong X, Kun LE, Boop FA, Sanford RA,. Conformal radiotherapy after surgery for paediatric ependymoma: A prospective study. Lancet Oncol. 2009; 10: 258-266.
6. Koshy M, Rich S, Merchant TE, Mahmood U, Regine WF, Kwok Y,. Post-operative radiation improves survival in children younger than 3 years with intracranial ependymoma. J. Neurooncol. 2011; 105: 583-590.
7. Conklin HM, Li C, Xiong X, Ogg RJ, Merchant TE,. Predicting change in academic abilities after conformal radiation therapy for localized ependymoma. J. Clin. Oncol. 2008; 26: 3965-3970.
8. Merchant TE, Kiehna EN, Li C, Xiong X, Mulhern RK,. Radiation dosimetry predicts IQ after conformal radiation therapy in pediatric patients with localized ependymoma. Int. J. Radiat. Oncol. Biol. Phys. 2005; 63: 1546-1554.
9. Netson KL, Conklin HM, Wu S, Xiong X, Merchant TE,. A 5-year investigation of children's adaptive functioning following conformal radiation therapy for localized ependymoma. Int. J. Radiat. Oncol. Biol. Phys. 2012; 84: 217-223.
10. Merchant TE, Hua CH, Shukla H, Ying X, Nill S, Oelfke U,. Proton versus photon radiotherapy for common pediatric brain tumors: Comparison of models of dose characteristics and their relationship to cognitive function. Pediatr. Blood Cancer 2008; 51: 110-117.
11. Oshiro Y, Mizumoto M, Okumura T, et-‰al. Clinical results of proton beam therapy for advanced neuroblastoma. Radiat. Oncol. 2013; 8: 142.
12. Mizumoto M, Tsuboi K, Igaki H, et-‰al. Phase I/II trial of hyperfractionated concomitant boost proton radiotherapy for supratentorial glioblastoma multiforme. Int. J. Radiat. Oncol. Biol. Phys. 2010; 77: 98-105.
13. Oshiro Y, Mizumoto M, Okumura T, et-‰al. Results of proton beam therapy without concurrent chemotherapy for patients with unresectable stage III non-small cell lung cancer. J. Thorac. Oncol. 2012; 7: 370-375.
14. Mizumoto M, Okumura T, Hashimoto T, et-‰al. Proton beam therapy for hepatocellular carcinoma: A comparison of three treatment protocols. Int. J. Radiat. Oncol. Biol. Phys. 2011; 81: 1039-1045.
15. Mizumoto M, Sugahara S, Okumura T, et-‰al. Hyperfractionated concomitant boost proton beam therapy for esophageal carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 2011; 81: e601-606.
16. Mizumoto M, Sugahara S, Nakayama H, et-‰al. Clinical results of proton-beam therapy for locoregionally advanced esophageal cancer. Strahlenther. Onkol. 2010; 186: 482-488.
17. Mizumoto M, Okumura T, Ishikawa E, et-‰al. Reirradiation for recurrent malignant brain tumor with radiotherapy or proton beam therapy. Strahlenther. Onkol. 2013; 189: 656-663.
18. Gerweck LE, Kozin SV,. Relative biological effectiveness of proton beams in clinical therapy. Radiother. Oncol. 1999; 50: 135-142.
19. Paganetti H, Niemierko A, Ancukiewicz M, et-‰al. Relative biological effectiveness (RBE) values for proton beam therapy. Int. J. Radiat. Oncol. Biol. Phys. 2002; 53: 407-421.
20. Oshiro Y, Okumura T, Mizumoto M, et-‰al. Proton beam therapy for unresectable hepatoblastoma in children: Survival in one case. Acta Oncol. 2013; 52: 600-603.
21. Kanemoto A, Oshiro Y, Sugahara S, et-‰al. Proton beam therapy for inoperable recurrence of bronchial high-grade mucoepidermoid carcinoma. Jpn J. Clin. Oncol. 2012; 42: 552-555.
22. Mizumoto M, Hashii H, Senarita M, et-‰al. Proton beam therapy for malignancy in Bloom syndrome. Strahlenther. Onkol. 2013; 189: 335-338.
23. MacDonald SM, Safai S, Trofimov A, et-‰al. Proton radiotherapy for childhood ependymoma: Initial clinical outcomes and dose comparisons. Int. J. Radiat. Oncol. Biol. Phys. 2008; 71: 979-986.
24. Miralbell R, Lomax A, Cella L, Schneider U,. Potential reduction of the incidence of radiation-induced second cancers by using proton beams in the treatment of pediatric tumors. Int. J. Radiat. Oncol. Biol. Phys. 2002; 54: 824-829.